Blue Trust’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Blue Trust's MRNA Position: Q3 2026 in Review
Blue Trust reduced its Moderna (MRNA) stake by 21% in Q3 2026, selling an estimated $25.1K and leaving 889 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #819.
Blue Trust first reported a position in MRNA in Q2 2022 and has held it in 18 quarters since. 877 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Blue Trust held 889 shares of Moderna worth $171K as of Q3 2026.
- Blue Trust sold 233 Moderna shares in Q3 2026, an estimated $25.1K.
- Moderna made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #819 holding.
- Blue Trust first reported a position in Moderna in Q2 2022 and has held it in 18 quarters since.
- 877 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.